Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

    Recruiting

    3 1 1 1
    France Germany Poland
  • Study of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark Germany Norway Spain Sweden
  • Study of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study of dostarlimab treatment before surgery in patients with stage II-III endometrial cancer with specific genetic markers

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Spain
  • Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

    Recruiting

    3 1 1 1
    Bulgaria Czechia France Germany Greece Hungary +3
  • Study of Faricimab treatment to improve vision in patients with diabetic macular edema using adaptive optics imaging

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

    Recruiting

    2 1 1 1
    Germany
  • Study comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France